U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C65H96N16O12S2
Molecular Weight 1357.688
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEPREOTIDE

SMILES

CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC4=CC=C(O)C=C4)NC(=O)[C@H](CC5=CC=CC=C5)N(C)C(=O)[C@H](CCSCC(=O)NC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(N)=O)NC1=O

InChI

InChIKey=XXXSJQLZVNKRKX-YQRDHHIGSA-N
InChI=1S/C65H96N16O12S2/c1-38(2)55-64(92)76-49(26-30-95-37-54(83)72-35-44(69)57(85)74-47(20-10-13-28-67)58(86)79-52(36-94)62(90)73-46(56(70)84)19-9-12-27-66)65(93)81(3)53(32-39-15-5-4-6-16-39)63(91)78-50(31-40-22-24-42(82)25-23-40)60(88)77-51(33-41-34-71-45-18-8-7-17-43(41)45)61(89)75-48(59(87)80-55)21-11-14-29-68/h4-8,15-18,22-25,34,38,44,46-53,55,71,82,94H,9-14,19-21,26-33,35-37,66-69H2,1-3H3,(H2,70,84)(H,72,83)(H,73,90)(H,74,85)(H,75,89)(H,76,92)(H,77,88)(H,78,91)(H,79,86)(H,80,87)/t44-,46-,47-,48-,49-,50-,51+,52-,53-,55-/m0/s1

HIDE SMILES / InChI

Molecular Formula C65H96N16O12S2
Molecular Weight 1357.688
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 2
Optical Activity UNSPECIFIED

Depreotide is an ingredient in the diagnostic aid (radioactive imaging agent). Technetium Tc 99m labeled depreotide is a scintigraphic imaging agent that identifies somatostatin receptor-bearing pulmonary masses in patients presenting with pulmonary lesions on computed tomography and/or chest x-ray who have known malignancy or who are highly suspect for malignancy. Adverse events were evaluated in clinical studies of 647 adults. Deaths did not occur during the clinical study period. After Technetium Tc 99m Depreotide Injection, serious adverse events were not reported. Headache was the most commonly reported adverse event. EMA withdrew depreotide containing agent NeoSpect.

Approval Year

Patents

Patents

Sample Use Guides

Single dose of 15 to 20 mCi containing approximately 47ug of Technetium Tc 99m radiolabeled Depreotide peptide.
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:45:05 GMT 2023
Edited
by admin
on Fri Dec 15 15:45:05 GMT 2023
Record UNII
NDP0H8E844
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEPREOTIDE
INN   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
DEPREOTIDE [MI]
Common Name English
CYCLO(L-HOMOCYSTEINYL-N-METHYL-L-PHENYLALANYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL), (1->1')-SULFIDE WITH 3-(2-MERCAPTOACETAMIDO)-L-ALANYL-L-LYSYL-L-CYSTEINYL-L-LYSINAMIDE
Common Name English
DEPREOTIDE [USAN]
Common Name English
CYCLO(L-HOMOCYSTEINYL-N-METHYL-L-PHENYLALANYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL) (1->1')-SULPHIDE WITH 3-((MERCAPTOACETYL)AMINO)-L-ALANYL-L-LYSYL-L-CYSTEINYL-L-LYSINAMIDE
Common Name English
Depreotide [WHO-DD]
Common Name English
P-829
Code English
depreotide [INN]
Common Name English
CYCLO(L-HOMOCYSTEINYL-N-METHYL-L-PHENYLALANYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL) (1->1')-SULFIDE WITH 3-((MERCAPTOACETYL)AMINO)-L-ALANYL-L-LYSYL-L-CYSTEINYL-L-LYSINAMIDE
Common Name English
CYCLO(L-HOMOCYSTEINYL-N-METHYL-L-PHENYLALANYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL), (1->1')-SULPHIDE WITH 3-(2-MERCAPTOACETAMIDO)-L-ALANYL-L-LYSYL-L-CYSTEINYL-L-LYSINAMIDE
Common Name English
P829
Code English
Classification Tree Code System Code
NCI_THESAURUS C62799
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
Code System Code Type Description
CAS
161982-62-3
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
NCI_THESAURUS
C83660
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
DRUG CENTRAL
2954
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
FDA UNII
NDP0H8E844
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
USAN
JJ-40
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
SMS_ID
100000092122
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
PUBCHEM
9898619
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
EVMPD
SUB22083
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
EPA CompTox
DTXSID301026951
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
INN
7800
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
ChEMBL
CHEMBL1908335
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
DRUG BANK
DB11628
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY
MERCK INDEX
m4182
Created by admin on Fri Dec 15 15:45:05 GMT 2023 , Edited by admin on Fri Dec 15 15:45:05 GMT 2023
PRIMARY Merck Index
Related Record Type Details
PARENT -> DERIVATIVE
SALT/SOLVATE -> PARENT
TARGET->LIGAND
TARGET->LIGAND
SALT/SOLVATE -> PARENT
LABELED -> NON-LABELED
TARGET->LIGAND
Related Record Type Details
ACTIVE MOIETY